# Open-label Milnacipran for Persistent Knee Pain One Year After Total Knee Arthroplasty (TKA)

> **NCT01780389** · PHASE4 · COMPLETED · sponsor: **Duke University** · enrollment: 5 (actual)

## Conditions studied

- Knee Pain After Total Knee Arthroplasty
- Osteoarthritis Pain

## Interventions

- **DRUG:** Open-label flexibly dosed milnacipran

## Key facts

- **NCT ID:** NCT01780389
- **Lead sponsor:** Duke University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-10
- **Primary completion:** 2011-07
- **Final completion:** 2011-07
- **Target enrollment:** 5 (ACTUAL)
- **Last updated:** 2015-02-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01780389

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01780389, "Open-label Milnacipran for Persistent Knee Pain One Year After Total Knee Arthroplasty (TKA)". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01780389. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*